An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

NCT02763761 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Insufficient enrollment

Conditions

Renal Cell Carcinoma
Melanoma
Lung Cancer

Interventions

DRUG: Infliximab + Prednisone
DRUG: Methylprednisolone + Prednisone

Sponsor

Bristol-Myers Squibb